Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects
  • Home
  • FDA Approval Process for Medical Devices

FDA (Food and Drug Administration) Approval Process for Medical Devices Training Course

This seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States including the underlying legal and regulatory requirements and the 'general controls' applicable to all devices.

22-23 Jun 2022

& 12-13 Sep 2022 , 5-6 Dec 2022

Book now

Details

Course overview

This seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States. Participants will gain an understanding of the underlying legal and regulatory requirements and the general controls applicable to all devices, including device classification, establishment registration and device listing. With the underlying framework in mind, the approval and clearance processes for new and modified devices will be presented, including 510(k), IDE, PMA, HDE and De Novo applications. Application contents, review processes, timelines, and key guidance documents will be discussed for each major type of submission. Participants will also learn about the pre-submission process, which FDA strongly recommends
to help ensure the successful submission of novel devices.

Demonstrations of how to find key information in FDA databases will be presented using participants’ products and interests as examples. There will also be updates on recent legislation changes, new regulations and guidance documents.

Please note that while the law, regulations, principles and processes covered in the course apply to both medical devices and in-vitro-diagnostics (IVDs), the trainer’s primary experience is with medical devices.

Benefits of attending

Upon completion of this seminar, participants will:

  • Understand the overall FDA medical device regulatory process
  • Know what is required for 510(k), IDE, PMA, HDE and De Novo applications
  • Understand how FDA processes premarket submissions
  • Identify key guidance documents to help ensure a successful process
  • Determine when pre-submission interaction with FDA is recommended
  • Be aware of areas of change

Who should attend

This seminar is intended for regulatory, technical, clinical and quality professionals who require an understanding of the FDA medical device approval process. Management, legal, medical, marketing and other professionals who are interested in understanding the key principles of the medical device approval process will also benefit in attending.

Programme

MODULE 1 – Overview of US Medical Device Regulatory Principles


Part 2 - Introduction to US FDA

History, Structure and Mission of FDA


Part 3 - Overview of US Regulatory Process and Pathway

Including how to work with FDA and pre-submissions (Q-subs)

MODULE 2 – Medical Device Definition, Classification, Device Listing & Establishment Registration


Part 1 - Medical Device Definition, Classification, Device Listing & Establishment Registration


Part 2 – Classification Case Study


MODULE 3 – Submissions


Part 1 - Pre-Market Notification 510(k)


Part 2 – De-Novo / Automatic Class III Reclassification


Part 3 - Pre-Market Approval (PMA)


Part 4 – HDE & IDE (& IUO)


Part 5 – Submission Case Study


MODULE 4 – Borderline & Combination Products

Product Designation & Combination Products

Presenter

Jonathan Hughes (More...)

Jonathan Hughes, Ph.D., FTOPRA, has over 32 years of worldwide regulatory and clinical affairs experience across medical devices, drug / biologic – device combination products and in-vitro diagnostics. He has worked with medical device and pharmaceutical companies, both large and small, across multiple locations to help develop and execute regulatory strategies for market clearance, approval and access.

Jonathan has hands-on experience in a variety of therapeutic areas and has worked across different technologies and types of medical products including medicated devices (devices containing ancillary drug and biologic constituents), drug delivery systems and componentry, sterile and non-sterile disposables and durable equipment, in-vitro diagnostics, software controlled devices and standalone software (including mobile apps). He has experience of regulating medical devices and combination products across most international markets including the European Union, US, Japan, China, Canada and Australia.

Jonathan specialises in regulatory strategy, regulatory and clinical development pathways, worldwide regulatory submissions and training. He has a strong knowledge of quality management systems and has direct hands-on experience of EU NB, MDSAP, US FDA, Brazilian ANVISA and Chinese NMPA inspections. He has worked with all the major international regulatory agencies, in particular (multiple) Notified Bodies and EU Competent Authorities, Japanese PMDA, US FDA, Chinese NMPA.

Jonathan has served on two European Commission Expert Working Groups on the Drug / Device Borderline and Device Classification. He is a Fellow of the regulatory professional organisation, TOPRA, and is a regular contributor on numerous educational and training programmes. Jonathan has registered teacher status at Cranfield University, is a Visiting Industrial Fellow at the University of Hertfordshire and also a visiting lecturer at University of Newcastle upon Tyne.

Book now

Book now

NEW higher discounts for booking multiple places - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate
  • 40% off the 3rd delegate
  • 50% off the 4th delegate
22-23 Jun 2022
Live webinar
09:15-17:00
UK (London)
22-23 Jun 2022
Live webinar
09:15-17:00
UK (London)
GBP 1,299.00
EUR 1,859.00
USD 2,098.00
+ VAT @ 20.00%
Enrol now
to attend
Live webinar
12-13 Sep 2022
Live webinar
09:15-17:00
UK (London)
12-13 Sep 2022
Live webinar
09:15-17:00
UK (London)
GBP 1,299 1,099
EUR 1,859 1,579
USD 2,098 1,786
Until 8 Aug*
Enrol now
to attend
Live webinar
5-6 Dec 2022
Face-to-face, Rembrandt Hotel London
09:15-17:00
UK (London)
5-6 Dec 2022
Face-to-face
Rembrandt Hotel London
09:15-17:00
UK (London)
GBP 1,499 1,299
EUR 2,099 1,819
USD 2,338 2,026
Until 31 Oct*
Enrol now
to attend
Face-to-face
Rembrandt Hotel London
  • 2 days classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code. As such, discounts for the 2nd/3rd/4th attendees are based on the full price of the course. Please contact us for pricing if you wish to send more than 4 delegates.

Continuing professional development

This course qualifies for 12 hours for your CPD records.
More about CPD

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • 42 Technology Ltd
  • ABBOTT IRELAND
  • Air Liquide Santé International
  • Annette Callaghan Ltd
  • Bedfont Scientific Ltd
  • Biogen Idec Ltd
  • CAMBRIDGE BIOSTABILITY
  • Carl Zeiss AG
  • Carl Zeiss Meditec
  • DCA Design International
  • Diagnostic Grifols
  • Engineers & Doctor As
  • Eurofins Biolab Srl
  • Grifols, S.A
  • GSK Consumer Healthcare
  • Henkel Operations and Research Ltd
  • Informa Healthcare Limited
  • ING. ERICH PFEIFFER GmbH
  • Invatec SRL
  • JOHNSON & JOHNSON
  • MAGSTIM CO LTD
  • Mobidiag Oy
  • Owen Mumford Ltd
  • Oystershell NV
  • Pfizer
  • Pfizer R&D UK Ltd
  • Quanta Dialysis Technologies Ltd
  • Roche Diabetes Care GmbH
  • VASCUTEK LTD
  • ZIMMER GMBH

Absolutely fantastic. I needed to be able to communicate more effectively with my Regulatory colleagues and I believe the information I have learned on this course will assist me to do that

Jenny Ramsey, Quality Engineer - Compliance, Pfizer R&D UK Ltd, Mar 22

All was great, no complaints!

Angelica Morreno, Regulatory Affairs Assistant, Sinclair Pharmaceuticals, Mar 22

I was hoping to get more information regarding 510(k) submissions. I am very happy that I got the opportunity to learn much more. I learned a lot and feel more confident about my understanding of the submission processes.

Natale Rolim, Project Manager, EpiGuard, Mar 22

I was happy to attend to this webinar and it was really useful and well-explained and organized.

Mireia Crosa, Regulatory and Compliance Specialist, Diagnostic Grifols, S.A., Mar 22

A good and well thought out webinar with very intelligent presenter.

Ifesinachi Onyekaba, Research and Development Specialist, MEDTRON AG, Sep 21

Very useful overview of the FDA medical device pathways to market with valuable documentation.

Angela Sauerwald, VP Product Safety,Clinical & Regulatory Affairs at Essity, Essity - BSN medical GmbH, Sep 20

It was an excellent training and covers US FDA MD regulation framework. Workshops were very useful.

Ilker Yilmaz, International Regulatory Affairs Manager, GAMA Healthcare Ltd, Sep 20

The course gives a very nice overview; especially valuable when you are just starting to considering to apply for FDA market clearance. (The speaker was) very knowledgeable about the FDA approval procedure for MDs in general. Mark is a good speaker, approachable, and he leaves plenty of room for discussion.

Ivo van Bostelen, Project Leader, MRC-Holland BV, Mar 19

The course was good and a thorough run through of the FDA approval process, with an easy to understand Mark Kramer.

Jens Johansen, QA/RA Director, RSP Systems, Mar 19

I’m very pleased with the overall learning objectives, presentations and the quality of the handout given at the course. Good presentation and good focus on driving the presentations forward. A bit difficult to coordinate presentation with time table given in handouts.

Jarle Mikalsen, CSO, Lyfstone, Mar 19

[The course] was all very good and very informative. Very informative content given by a very knowledgeable speaker on a complex area, but I now have a much better understanding of the overall submission processes.

Simon Collings, Director, IDC, Oct 18

Mark was a very good speaker and it was clear from the start that he was very knowledgeable. The course was well structured, pitched at the right level for the attendees, in a clear and concise manner, with plenty of opportunity to ask questions.

Adam Williams, Senior Quality Engineer, Sharp Life Science (EU) Ltd, Oct 18

I met Mark Kramer in a previous course of Combination Products. His explanations are very clear, I can perceive that he knows how FDA works, what FDA expects to get for every situation. I have enjoyed a lot and think it's been very profitable. Mark answered all our questions being pretty interactive. The course is about a general and consistent view of the FDA approval processes for medical devices, clear and comprenhensive presentation. I can sense that Mark knows very well how FDA works and what FDA expects. Very profitable and highly recommended to catch a general knowledge.

Maria Jose Hijarrubia Ibrahim, Medical Devices Registers, Grifols S.A, Oct 18

I immensely enjoyed Mark's presentation, he is a very good speaker - conveying information in a clear and comprehensive manner, attentive, and responsive to the participants' needs.

Christina Zavadsky, QARA Manager, Zilico, Apr 18

Excellent! Lots of Q&A, interactive session make the topic fun. Speaker has lots of experiences and strategic thinking.

Cadence Tan, Senior Regulatory Affairs Manager, GSK Consumer Healthcare, Apr 18